Exploring metabolic candidates and inflammatory mediation in Parkinson’s disease: a pilot integrative metabolomics and Mendelian randomization study
Parkinson’s disease (PD) is a complex neurodegenerative disorder characterized by multifaceted molecular dysregulation. Integrating genetic approaches with metabolomics may help to systematically investigate potential links between metabolites, inflammatory proteins, and PD risk. In this pilot discovery ph...